MedPath
NMPA Approval

Montelukast Sodium Oral Granules

国药准字J20140167

July 31, 2019

H20150419H20150431H20171062

Drug Information

孟鲁司特钠颗粒

顺尔宁

顺尔宁

颗粒剂

0.5g:4mg(以孟鲁司特计)

July 31, 2019

Company Information

Applicant Company

30 Hudson St F133,Jersey City, NJ 07302 United States of America

Manufacturing Company

5900 Martin Luther King Jr. Highway, Greenville, NC, 27834

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

孟鲁司特钠颗粒 - NMPA 批准文号 | MedPath